Determination of Insulin-Like Growth Factor-I in the Monitoring of Growth Hormone Treatment with Respect to Efficacy of Treatment and Side Effects: Should Potential Risks of Cardiovascular Disease and Cancer Be Considered?
1999 ◽
Vol 51
(3)
◽
pp. 141-148
◽
1990 ◽
Vol 79
(s370)
◽
pp. 28-34
◽
2007 ◽
Vol 92
(11)
◽
pp. 4172-4179
◽
2002 ◽
Vol 80
(4)
◽
pp. 1074-1082
◽
1997 ◽
Vol 241
(2)
◽
pp. 143-150
◽